Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
How do I get data feeds? Choose from our ready-to-go selection of data feeds or select your own custom set of data. Evaluate will work in collaborative partnership through our Consulting and Analytics team to maximise the value of our data and ensure actionable outcomes. Our team works with you to ensure the approach and outcomes are fit for purpose and designed to your specific needs. Whatever your choice, we’ll ensure the data you need is delivered in the way that you need, when you need it.
We provide you with programmatic access to machine readable and database-friendly Evaluate data that can be integrated into CRM systems, analytics dashboards and other applications. There’s no more need to manually download and update your data. This also enables you to combine Evaluate data with other internal and external data ensuring that you find that vital insight that substantiates all your key commercial decisions.
Core pipeline and marketed pharmaceutical product data providing insight into R&D pipelines, company portfolios, and competitive landscapes helping to make better asset screening, forecasting, modelling and investment decisions
Understand historical sales performance of a product, sales trends for key segments, and market evolution enabling you to get a more holistic picture of changes over time
Assess the predicted future evolution of the market, sales potential for key products, and inform market sizing to ensure you deliver maximum return on investment.
Deeper insights into market evolution and product sales potential by specific labelled or investigatory indication.
Powerful insights into pharmaceutical ROI at the product and indication level, including product-specific success rates, anticipated future development timelines, and predicted peak sales in the USA.
Consistent company profiles including name, address, and company classification, alongside portfolio insights including pipeline counts by phase/therapy area, and analysis of sales concentration, risk, and age profile.
Understand the historical and forecast future performance of a company including key P&L and balance sheet items (such as revenue, R&D spend), coupled with Evaluate exclusive segment and therapy area sales breakdowns.
Insight into fundraising efforts and funding status of pharmaceutical companies (including private companies), and into activities of specific venture financing firms.
Understand ownership and market sales rights for pharmaceutical products, including proportion of sales booked in key territories by company, and profiles of deals signed including deal types and terms.
Assess ongoing clinical trial activity by indication and other factors, augmented with clinical outcome summaries (interim and final readouts) and with clean mapping to primary pharmaceutical products.
Stay up to date with industry developments and benefit from insightful analysis and commentary from the Evaluate Vantage team.